Fenretinide treatment of geographic atrophy in dry AMD: Preliminary results

Retina Today

Volumn , Issue OCTOBER, 2010, Pages 57-58

  Eaton, Alexander M ^a  

^a Retina Health Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 82255180668     PISSN: None     EISSN: 18250572     Source Type: Journal    
DOI: None     Document Type: Note

References (3)

1. Sparrow JR, Kim SR, Wu Y. Experimental approaches to the study of A2E, a bisretinoid lipofuscin chromophore of retinal pigment epithelium. Methods Mol Biol. 2010;652:315-327.
2. Radu RA, Han, Y, Bui T, et al. Reductions in serum vitamin A arrest accumulation of toxic retinal fluorophores: a potential therapy for treatment of lipofuscin-based retinal diseases. Invest Ophthalmol Vis Sci. 2005;46:4393-4401.
3. Eaton AM, Slakter JS, McLead K, et al. Pilot study of the efficacy and safety of fenretinide 100mg and 300mg compared to placebo in subjects with geographic atrophy (GA). Paper presented at: American Society of Retina Specialists annual meeting; Vancouver, Canada.